Pharmaceutical Mutual funds are funds which primarily invest in pharmaceutical stocks in India.
Since these mutual funds invest money in a single theme/sector, they are categorized as High Risk equity investments.
| Mutual Fund Scheme | NAV | Month | 3 Month | 6 Month | Year | 2 Year | 3 Year | As on (yy-mm-dd) |
|---|---|---|---|---|---|---|---|---|
| Reliance Pharma Fund - Direct Plan Growth Plan - Growth Option | 155.5 | -2.92% | -10.54% | 8.14% | 7.34% | 6.46% | 4.60% | 2018-12-07 |
| Reliance Pharma Fund-Growth Plan-Growth Option | 148.1 | -3.00% | -10.74% | 7.66% | 6.39% | 4.60% | 1.82% | 2018-12-07 |
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 9.1 | -2.26% | -12.28% | 4.86% | 1.80% | -1.73% | NA | 2018-12-07 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 8.6 | -2.38% | -12.66% | 3.98% | 0.00% | -4.96% | NA | 2018-12-07 |
| UTI Pharma & Healthcare Fund-Income Option-Direct | 66.9 | -2.55% | -15.01% | 1.36% | -4.97% | -7.19% | -9.01% | 2018-12-07 |
| UTI Pharma & Healthcare Fund-Growth Option- Direct | 86.5 | -2.55% | -15.00% | 1.37% | -4.98% | -7.19% | -9.00% | 2018-12-07 |
| UTI Pharma & Healthcare Fund-Growth Option | 82.1 | -2.63% | -15.24% | 0.82% | -5.97% | -8.99% | -11.59% | 2018-12-07 |
| UTI Pharma & Healthcare Fund-Income Option | 63.4 | -2.64% | -15.24% | 0.83% | -5.98% | -9.00% | -11.60% | 2018-12-07 |
| SBI PHARMA - DIRECT PLAN -GROWTH | 125.6 | -2.67% | -12.97% | 6.07% | -6.62% | -11.78% | -17.00% | 2018-12-07 |
| SBI PHARMA - REGULAR PLAN -GROWTH | 117.6 | -2.76% | -13.22% | 5.41% | -7.78% | -13.90% | -20.02% | 2018-12-07 |
